OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma
Jiacheng Huang, Lele Zhang, Jianxiang Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Jiacheng Huang, Lele Zhang, Jianxiang Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Showing 14 citing articles:
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
Xinyan Wu, Zhigang Zhou, Qiang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Xinyan Wu, Zhigang Zhou, Qiang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
Anuradha Budhu, Erica C. Pehrsson, Aiwu Ruth He, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101052-101052
Open Access | Times Cited: 15
Anuradha Budhu, Erica C. Pehrsson, Aiwu Ruth He, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101052-101052
Open Access | Times Cited: 15
Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
Mutaz Jamal Al-Khreisat, Nor Hayati Ismail, Abedelmalek Tabnjh, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2068-2068
Open Access | Times Cited: 11
Mutaz Jamal Al-Khreisat, Nor Hayati Ismail, Abedelmalek Tabnjh, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2068-2068
Open Access | Times Cited: 11
Cytokine response against Epstein–Barr virus infection
Priyanka Basera, Shuchishloka Chakraborty, Meeta Lavania, et al.
Elsevier eBooks (2025), pp. 43-51
Closed Access
Priyanka Basera, Shuchishloka Chakraborty, Meeta Lavania, et al.
Elsevier eBooks (2025), pp. 43-51
Closed Access
Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line
Jiacheng Huang, Mengqing Sun, Menglan Wang, et al.
Bioengineered (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Jiacheng Huang, Mengqing Sun, Menglan Wang, et al.
Bioengineered (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Current and developing strategies
Josepmaria Argemí, Mariano Ponz‐Sarvisé, Bruno Sangro
Advances in cancer research (2022), pp. 367-413
Closed Access | Times Cited: 13
Josepmaria Argemí, Mariano Ponz‐Sarvisé, Bruno Sangro
Advances in cancer research (2022), pp. 367-413
Closed Access | Times Cited: 13
Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
Yimin Liang, Shijie Su, Zhaoxia Lun, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Yimin Liang, Shijie Su, Zhaoxia Lun, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Guang Wang, Juan Fu, Mulin Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0277872-e0277872
Open Access | Times Cited: 1
Guang Wang, Juan Fu, Mulin Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0277872-e0277872
Open Access | Times Cited: 1
Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper
Mariona Pascal, Heather J. Bax, Christoph Bergmann, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2319-2345
Open Access | Times Cited: 1
Mariona Pascal, Heather J. Bax, Christoph Bergmann, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2319-2345
Open Access | Times Cited: 1
ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer
Meiwen Lv, Xuelian Li, Wen Tian, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 5
Meiwen Lv, Xuelian Li, Wen Tian, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 5
LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway
Lixin Chen, Ji Qian, Qinghua You, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 10089-10100
Open Access | Times Cited: 6
Lixin Chen, Ji Qian, Qinghua You, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 10089-10100
Open Access | Times Cited: 6
Integrative bioinformatics analysis reveals ECM and nicotine-related genes in both LUAD and LUSC, but different lung fibrosis-related genes are involved in LUAD and LUSC
Marzyeh Alipour, Mehdi Moghanibashi, Sirous Naeimi, et al.
Nucleosides Nucleotides & Nucleic Acids (2024) Vol. 43, Iss. 9, pp. 915-934
Closed Access
Marzyeh Alipour, Mehdi Moghanibashi, Sirous Naeimi, et al.
Nucleosides Nucleotides & Nucleic Acids (2024) Vol. 43, Iss. 9, pp. 915-934
Closed Access
From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment
Nicholas Koelsch, Masoud H. Manjili
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12086-12086
Open Access | Times Cited: 1
Nicholas Koelsch, Masoud H. Manjili
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12086-12086
Open Access | Times Cited: 1
A Review on Cancer, Cause of Cancer and Treatment: Role of PIK3 Pathway on Cancer
Choudhary ML
Bioequivalence & Bioavailability International Journal (2023) Vol. 7, Iss. 2, pp. 1-17
Open Access | Times Cited: 1
Choudhary ML
Bioequivalence & Bioavailability International Journal (2023) Vol. 7, Iss. 2, pp. 1-17
Open Access | Times Cited: 1
